Takeaway
In short, this case makes Minnesota’s rule clear: a shareholder claim is direct when shareholders, rather than the corporation, suffered the alleged injury and would receive the recovery; collective shareholder injury alone does not make the claim derivative.
Medtronic, then a Minnesota corporation, announced a merger with Covidien structured as a corporate inversion. A newly formed Irish holding company acquired both companies; former Medtronic shareholders received one share in the new company for each old share and collectively owned about 70 percent of it, while former Covidien shareholders owned about 30 percent. The inversion moved Medtronic under Irish tax law.
Shareholder Kenneth Steiner challenged the transaction’s structure, not the underlying decision to merge. He alleged that Medtronic shareholders were injured because the inversion imposed capital-gains taxes on shareholders with taxable accounts, diluted their ownership and voting interests in the combined company, and treated them differently from corporate officers and directors whose transaction-related excise-tax liabilities Medtronic reimbursed. Steiner brought fiduciary-duty, Minnesota Business Corporation Act, and securities-law claims.
The district court concluded that Counts I through X alleged injuries to Medtronic and were therefore derivative claims. Because Steiner had not made a board demand or satisfied the particularized pleading requirements for derivative suits under Minn. R. Civ. P. 23.09, the court dismissed those counts. It dismissed the securities claims under Rule 12.02(e). The court of appeals held that most of the challenged claims were direct, except for the claim concerning reimbursement of officers’ and directors’ excise taxes. The Supreme Court granted review on the direct-versus-derivative question, while leaving the court of appeals’ securities-law rulings undisturbed.
Issue #1
Whether Minnesota should use a Delaware-derived test or Minnesota’s own framework to distinguish direct from derivative shareholder claims.
Holding
Minnesota law controls: the inquiry is who suffered the alleged injury and who would receive the benefit of any recovery.
Reasoning
A corporation is a legal entity separate from its shareholders. When a wrong injures the corporation, the claim belongs to the corporation, and a shareholder may pursue it only derivatively and subject to Rule 23.09’s demand and particularized-pleading requirements. A direct claim, by contrast, alleges an injury suffered by the shareholder rather than the corporate entity.
Minnesota precedent, including Wessin, Northwest Racquet, and the Seitz decisions, focuses on the nature of the injury and the proper recipient of the remedy. Although those cases used somewhat different language, they applied the same core analysis: identify whether the corporation or the shareholder was harmed and, correspondingly, whether recovery belongs to the corporation or the shareholder.
The court declined to adopt the court of appeals’ three-part formulation drawn from Delaware’s Tooley decision. Minnesota precedent adequately resolved the issue, and Tooley had been limited in Delaware to fiduciary-duty claims. Minnesota does not impose a separate requirement that a shareholder’s direct injury be distinct from injuries suffered by all other shareholders. A claim may be direct when shareholders are injured without a corresponding injury to the corporation, even if shareholders suffer that injury collectively.
Issue #2
Whether styling claims as violations of the Minnesota Business Corporation Act eliminates the need to determine whether they are direct or derivative.
Holding
No. Statutory claims under chapter 302A remain subject to the direct-versus-derivative analysis.
Reasoning
The character of a shareholder claim turns on the injury alleged, not on the legal theory or statutory provision pleaded. Wessin itself rejected the argument that all chapter 302A claims are automatically direct. Thus, Steiner could not avoid derivative-suit requirements merely by framing claims as violations of the Minnesota Business Corporation Act.
Issue #3
Whether claims challenging Medtronic’s reimbursement of officers’ and directors’ transaction-related excise-tax liabilities were direct claims.
Holding
No. Those claims were derivative and were properly dismissed for failure to comply with Rule 23.09.
Reasoning
The alleged reimbursement was, at bottom, an alleged misuse or waste of corporate assets. That conduct directly injured Medtronic because corporate funds were paid out improperly; any shareholder injury was only indirect, through the shareholder’s interest in the corporation.
The requested recovery also confirmed the derivative character of the claims. If the reimbursement were improper, the funds would be returned to Medtronic, not paid directly to shareholders. Because the corporation suffered the alleged injury and would receive the remedy, Counts VI through X were derivative.
Issue #4
Whether claims based on capital-gains taxes incurred by Medtronic shareholders as a result of the inversion were direct claims.
Holding
Yes. The capital-gains-tax claims were direct.
Reasoning
The alleged tax liability fell on shareholders who held Medtronic stock in taxable accounts solely because of their status as shareholders in the inversion transaction. Medtronic itself did not incur that capital-gains tax liability and therefore was not the party injured by it.
Any recovery for that injury would belong to the affected shareholders, rather than to Medtronic. Because the claimed harm was not shared by the corporation and the remedy would run to shareholders, the claims were direct and not subject to Rule 23.09.
Issue #5
Whether claims alleging dilution of Medtronic shareholders’ ownership and voting interests in the new company were direct or derivative.
Holding
They were direct claims at the pleading stage, so the district court erred in dismissing them under Rule 23.09.
Reasoning
Steiner did not allege merely that Medtronic overpaid for Covidien and thereby reduced the value of Medtronic’s assets. Such an overpayment theory ordinarily describes an injury to the corporation, with shareholders harmed only indirectly through a decline in share value.
Instead, Steiner alleged that Medtronic structured the inversion to secure and preserve its tax benefits by taking a portion of shareholders’ ownership interest and voting power in the combined company. That alleged expropriation affected the incidents of shareholder ownership directly, while, on Steiner’s allegations, it served rather than injured the corporation.
At the motion-to-dismiss stage, the court was required to accept those allegations as true. On that basis, dilution injured shareholders and not Medtronic, making the claims direct. The court did not decide whether Steiner could ultimately prove the dilution claims.